SCHEMBL19166135

SCHEMBL19166135

c1ccc(N(c2ccccc2)c2ccc(-c3ccc4c(c3)-c3ccccc3-c3ccccc3C43c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PDK2 Q15119 14/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ATM Q13315 2/20 0.39
APAF1 O14727 1/20 0.39
NPC1 O15118 1/20 0.39
THRB P10828 1/20 0.39
XBP1 P17861 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19167709 0.98 MAPT (0.41) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL19166069 0.98 MAPT (0.41) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL19168608 0.97 MAPT (0.42) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL19166299 0.97 MAPT (0.42) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL15213737 0.95 PDK2 (0.43) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL24646771 0.94 PDK2 (0.40) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL16810682 0.94 PDK2 (0.42) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL24750747 0.92 PDK2 (0.39) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL23449543 0.92 PDK2 (0.39) MAPTL3MBTL1KDM4EALDH1A1CYP1A2
SCHEMBL22182309 0.92 PDK2 (0.39) MAPTL3MBTL1KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10424744-B2 Compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-09-24 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed
US-20170213971-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10424744-B2 Compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 MAPT 3359/4885L3MBTL1 672/4885KDM4E 901/4885
US-20170213971-A1 Novel compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 MAPT 3144/4885L3MBTL1 734/4885KDM4E 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.